Strategies Wealth Advisors, LLC Immunic, Inc. Transaction History
Strategies Wealth Advisors, LLC
- $916 Billion
- Q2 2025
A detailed history of Strategies Wealth Advisors, LLC transactions in Immunic, Inc. stock. As of the latest transaction made, Strategies Wealth Advisors, LLC holds 100,000 shares of IMUX stock, worth $93,000. This represents 0.01% of its overall portfolio holdings.
Number of Shares
100,000Holding current value
$93,000% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding IMUX
# of Institutions
71Shares Held
47MCall Options Held
1.14MPut Options Held
130K-
Bvf Inc San Francisco, CA8.9MShares$8.28 Million0.43% of portfolio
-
Abrdn PLC8.24MShares$7.67 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT7.29MShares$6.78 Million0.66% of portfolio
-
Avidity Partners Management LP Dallas, TX4.45MShares$4.14 Million1.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.93MShares$3.66 Million0.0% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $28.4M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...